TITLE

Extraosseous uptake of metastatic lymph nodes of ureteral cancer on 99Tcm hydroxymethylene diphosphonate bone scintigraphy

AUTHOR(S)
Kaida H; Ishibashi M; Baba K; Nishida H; Matsuoka K; Hayabuchi N
PUB. DATE
October 2004
SOURCE
British Journal of Radiology;Oct2004, Vol. 77 Issue 922, p869
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
16977588

 

Related Articles

  • Bone single photon emission computed tomography with computed tomography disclosing chronic uterine perforation with intrauterine device migration into the anterior wall of the bladder: a case report. Morland, David; Mathelin, Carole; Wattiez, Arnaud; Namer, Izzie Jacques // Journal of Medical Case Reports;2013, Vol. 7 Issue 1, p1 

    Introduction: Extraosseous uptake of 99mTc-hydroxymethylene diphosphonate is a common situation of variable clinical relevance. Case presentation: A 52-year-old Caucasian woman presented to our department for breast cancer staging. A 99mTc-hydroxymethylene diphosphonate bone scan was performed...

  • Urinary bladder carcinoma associated with Paget's disease of skull: Imaging findings on Tc99m-MDP bone scintigraphy, F18-Fluoride PET/CT and F18-FDG PET/CT. Chakraborty, Dhritiman; Mittal, Bhagwant Rai; Kamaleshwaran, Koramadai Karuppuswamy; Kashyap, Raghava; Bhattacharya, Anish; Kumar, Santosh // Indian Journal of Nuclear Medicine;Jan-Mar2011, Vol. 26 Issue 1, p42 

    We report the imaging findings of a patient with Paget's disease in metastatic carcinoma bladder evaluated by Tc99m- Methylene diphosphonate (MDP) bone scintigraphy, F18-Fluoride positron emission tomography/computed tomography (PET/CT) and F18-fluorodeoxy glucose (FDG) PET/CT. Tc99m-MDP bone...

  • Tc99m-MDP uptake in ascitic fluid in a patient with prostate carcinoma: A clue to detect metastases. Chakraborty, Dhritiman; Manohar, Kuruva; Kamleshwaran, Koramadai Karuppuswamy; Bhattacharya, Anish; Singh, Baljinder; Mittal, Bhagwant Rai // Indian Journal of Nuclear Medicine;Jul2011, Vol. 26 Issue 3, p161 

    Bone scintigraphy with Tc-99m methylene diphosphonate (MDP) is used to detect metastases in patients with cancer. Uptake in non-osseous, non-urologic tissues is occasionally found in the routine bone scintigraphy, which may mimic as metastatic lesions. The authors describe the case of a...

  • Camurati—Engelmann disease on a 99mTc-HMDP bone scan. Momose, Mitsuhiro; Yoshida, Kunihiro; Yanagisawa, Shin; Kadoya, Masumi // European Journal of Nuclear Medicine & Molecular Imaging;Nov2008, Vol. 35 Issue 11, p2143 

    The article reports a case of a woman with Camurati-Engelmann disease (CED). The patient complained of bilateral lower legs' pain, general fatigue, and muscle weakness. Tc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy revealed multi-uptakes in the bilateral upper and lower limbs,...

  • Extraosseous accumulation of bone scan tracer 99mTc-methylene diphosphonate in a phlebolith. Kulkarni, Mukta; Agrawal, Archi; Zade, Anand; Purandare, Nilendu; Shah, Sneha; Rangarajan, Venkatesh // Indian Journal of Nuclear Medicine;Jan2012, Vol. 27 Issue 1, p42 

    Uptake in non-osseous, non-urologic tissues is occasionally found in the performance of bone scintigraphy. These uptakes reflect an atypical interaction between the radiopharmaceutical and the patient. Knowledge of the rare extraskeletal uptakes and their clinical relevance helps in better...

  • 99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer. Mena, Esther; Camacho, Valle; Estorch, Montserrat; Fuertes, Jordi; Flotats, Albert; Carrió, Ignasi // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 10, p1399 

    Purpose: Scintigraphy with 99mTc-depreotide, a somatostatin analogue-technetium ligand, has been used for evaluation of various malignant neoplasms, including lung cancer. The diagnosis of hone metastases in patients with lung cancer is not always definitive with current imaging methods....

  • Diffuse hepatic and splenic Tc-99m MDP tracer uptake in case of multiple myeloma. Sood, Ashwani; Seam, Rajeev Kumar; Sethi, Sandeep; Gupta, Manish // Indian Journal of Nuclear Medicine;Apr-Jun2010, Vol. 25 Issue 2, p70 

    Tc-99m methylene diphosphonate (MDP) bone scintigraphy has long been used for the evaluation of benign as well as malignant skeletal conditions. However, non-osseous tracer uptake on a bone scan is an unusual finding. There is a need to understand the pathophysiological basis of the non-osseous...

  • Extraosseous uptake of technetium-99m methylene diphosphonate by an acute territorial cerebral infarct in a classical biodistribution pattern. Kannivelu, Anbalagan; Padhy, Ajit Kumar; Srinivasan, Sivasubramanian; Ali, Syed Zama // Indian Journal of Nuclear Medicine;Oct2013, Vol. 28 Issue 4, p240 

    Technetium-99m methylene diphosphonate scintigraphy is usually performed to assess bone lesions, especially skeletal metastases in patients with a history of malignancy. However, it is important to recognize some specific conditions with a unique pattern of tracer uptake, especially in...

  • An uncommon case showing three different pathologies on 99mtechnetium-methylene diphosphonate bone scintigraphy. Chakraborty, Partha Sarathi; Karunanithi, Sellam; Dhull, Varun Singh; Kumar, Kunal; Gupta, Ravikant; Tripathi, Madhavi // Indian Journal of Nuclear Medicine;Jan-Mar2015, Vol. 30 Issue 1, p80 

    99mTechnetium-methylene diphosphonate bone scintigraphy (BS) has an important role in evaluating skeletal pathology, especially its extent. Incidental extra-osseous uptake may sometimes be seen in soft-tissue pathologies. We present a 64-year-old female with skull base osteomyelitis referred for...

  • Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Nakai, Takako; Okuyama, Chio; Kubota, Takao; Yamada, Kei; Ushijima, Yo; Taniike, Keiko; Suzuki, Takako; Nishimura, Tsunehiko // European Journal of Nuclear Medicine & Molecular Imaging;Nov2005, Vol. 32 Issue 11, p1253 

    Purpose: The purpose of this study was to investigate the pitfalls of using 2-[18F]-fluoro-2-deoxy-Dglucose positron emission tomography (FDG-PET) for the evaluation of osteoblastic bone metastases in patients with breast cancer by comparing it with 99mTc-hydroxymethylene diphosphonate bone...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics